RxDoctor Payments Data

Ronald Glick, DO

Dermatology · Mesa, AZNPI 1235134412

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $75,465 of the $91,200 with a category attached, or 82.7%. AbbVie accounts for 77.0% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2019 at $25,652 and has fallen 56.7% since, to $11,113 in 2025. Among dermatology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$91,200in general payments, 2019–2025

Across 505 payments — averaging $180.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$70K
  • Novartis$8K
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$7K
  • Sun Pharmaceutical Industries Inc.$853
  • Johnson & Johnson$806
  • LEO Pharma Inc.$663
  • plus $3K from 22 others

What the payments were for

  • Consulting fees$1,8002%
  • Speaking & faculty fees$75,46583%
  • Travel & lodging$3,2604%
  • Food & beverage$10,27111%
  • Education$4040%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$91,200 in reported general payments places this provider in the 95th percentile of 305 dermatology providers in Arizona.

See all dermatology providers in Arizona

Medicare billing

Part B allowed, 2024
$945,332
Medicare patients
2,241
Services billed
9,055

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa14$295,484
Enbrel SureclickEtanercept15$167,133
Dupixent PenDupilumab13$50,113
Fluorouracil109$7,943
Clobetasol Propionate134$5,378
Doxycycline Hyclate600$2,874
Triamcinolone Acetonide213$1,805
Alclometasone Dipropionate25$1,337
Metronidazole27$1,304
Gentamicin Sulfate26$877
Desonide11$838
Ketoconazole26$466
ValacyclovirValacyclovir Hcl15$360
Econazole Nitrate11$327
Mupirocin16$115

Paid to pharmacies, not to this prescriber.

Other dermatology in Mesa

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →